Abstract:T-cell antigen receptors (TCRs) exhibit inherent cross-reactivity which broadens the spectrum of epitopes that are recognizable by a finite TCR-repertoire but also carries the risk of autoimmunity. However, TCRs support also a high level of antigen specificity as they allow T-cells to discriminate single antigenic peptide/MHC complexes (pMHCs) against millions of structurally related self-pMHCs, in some cases based on the absence or presence of a single methyl-group. How TCRs manage to convey such seemingly contrary properties and why some T-cells become over time autoreactive despite negative thymic selection, has remained elusive. Here, we devised a non-invasive molecular live cell imaging platform to investigate the biophysical parameters governing stimulatory TCR:pMHC interactions in settings of autoreactivity and anti-viral responses - two extremes in T-cell antigen recognition. We show that CMV-specific CD8+ RA14-T-cells respond effectively to even a single HLA-A2/CMV (A2/CMV) antigen, with synaptic TCR:pMHC lifetimes lasting seconds. In contrast, cross-reactivity of type 1 diabetes (T1D)-associated CD8+ 1E6 T-cells towards HLA-A2/preproinsulin (A2/PPI) self-epitopes involved ten-fold less stable synaptic TCR interactions resulting in severely attenuated ZAP70 recruitment and downstream signaling. Compared to A2/CMV-engaged RA14 T-cells, 1E6-T-cells required for activation 4000 or more A2/PPI and at least 100-times as many simultaneously pMHC-engaged TCRs. In support of antigen discrimination, CD8 co-engagement of MHC class I (MHCI) strengthened both settings of TCR:pMHC interactions equally but was essential only for sensitized virus detection but not autorecognition (1000- versus 5-fold enhancement). We conclude that the binding dynamics of TCRs and CD8 with pMHC shape the boundaries of central tolerance in the physiological context of the phenomenal yet also differential T-cell antigen detection capacity, TCR-cross-reactivity and self-antigen abundance. Gained insights are integral to a molecular and quantitative understanding of CD8+ T-cell mediated autoimmunity and protective immunity against infections and cancer.

What problem does this paper attempt to address?

The problem this paper attempts to address is understanding how T cells can highly sensitively recognize foreign antigens while avoiding autoimmune responses, and exploring the molecular mechanisms involved in this process. Specifically, the researchers developed a non-invasive molecular live-cell imaging platform to measure the dynamic parameters of T cell antigen recognition, particularly in the extreme cases of autoimmunity and antiviral responses. The study found that for virus-specific T cells (such as CMV-specific RA14 T cells), even a single antigen molecule can trigger a strong immune response; whereas for self-antigen-specific T cells (such as 1E6 T cells associated with type 1 diabetes), thousands of times more antigen are required to activate them. This difference is mainly attributed to the different binding kinetics between the TCR and the antigen peptide/MHC complex (pMHC), as well as the mode of action of the co-receptor CD8. The findings contribute to a better understanding of the boundary between CD8+ T cell-mediated autoimmunity and protective immunity, and have direct implications for the design of T cell-based immunotherapies.

Deconstructing CTL-mediated autoimmunity through weak TCR-cross-reactivity towards highly abundant self-antigen

A molecular basis of human T cell receptor autoreactivity toward self-phospholipids

Peripheral self-reactivity regulates antigen-specific CD8 T-cell responses and cell division under physiological conditions

Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules

Reduced Self-Reactivity of an Autoreactive T Cell After Activation with Cross-reactive Non–Self-Ligand

Autoimmune Susceptibility Imposed by Public TCRβ Chains

Human autoreactive T cells recognize CD1b and phospholipids

A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen

Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the Thymus

T-switch-ing TCR specificity

Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity

The Influence of T Cell Development on Pathogen Specificity and Autoreactivity

Humanized Mice Reveal New Insights into the Thymic Selection of Human Autoreactive CD8+ T Cells

Breaking tolerance with engineered class I antigen-presenting molecules

Antigen-specific modulation of chronic experimental autoimmune encephalomyelitis in humanized mice by TCR-like antibody targeting autoreactive T-cell epitope

Antigen-Specific modulation of Chronic Experimental Autoimmune Encephalomyelitis in Humanized Mice by TCR-like Antibody Targeting Auto-Reactive T-Cell Epitope

Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases

Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity

Specific and non-specific autoreactive immunity

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms